About Aspire Bariatrics
Aspire Bariatrics was a Healthcare company based in King Of Prussia (United States) founded in 2004. Aspire Bariatrics is focused on weight loss solutions. It operates on a HealthTech model. Aspire Bariatrics has raised $29.44 million across 5 funding rounds from investors including Hercules Capital. The company has 7 employees. Its website aspirebariatrics.com draws about 681 thousand monthly visits. The company is recorded as dissolved. Aspire Bariatrics offers products and services including AspireAssist. Its focus areas include Medical Devices and Weight Loss Solutions. Its legal entity is Aspire Bariatrics, Inc. Its competitors include EnteroMedics, Elira and Endosphere; 3 of its 3 listed competitors have raised funding.
Company details
Aspire Bariatrics, Inc. is engaged in providing innovative weight loss solutions through medical devices. The companys primary product, AspireAssist, was developed to assist patients in managing weight loss. Operations are being wound down due to financial challenges caused by the COVID-19 pandemic, leading to the withdrawal of AspireAssist from the market as of April 8, 2022. The sector served includes healthcare with a focus on non-surgical weight loss interventions. No safety or effectiveness issues are associated with the product withdrawal.
- Headquarters King Of Prussia, United States
- Employees 7
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website aspirebariatrics.com
- Social Facebook
- Legal Name Aspire Bariatrics, Inc.
- Total Equity Funding$29.44M (USD)
in 5 rounds
- Latest Funding Round$4.63M (USD), Series A
Aug 2017
- Investors
- Employee Count7
Products & Services of Aspire Bariatrics
Aspire Bariatrics offers a comprehensive portfolio of products and services, including AspireAssist.
A device for weight loss assistance is provided.
Funding Insights of Aspire Bariatrics
Aspire Bariatrics has successfully raised a total of $29.44M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $4.63 million completed in August 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $29.44M
- Total Rounds 5
- Last Round Series A — $4.63M
- First Round $16.21M
(Dec 2011)
- Investors Count 1
All 5 funding rounds of Aspire Bariatrics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2017 | $4.63M | Series A | – | – | – |
| May 2016 | $3.57M | Series A | – | – | – |
| Jan 2015 | $12M | Debt – Conventional | – | – | |
| Jun 2014 | $5.03M | Series A | – | – | – |
| Dec 2011 | $16.21M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Aspire Bariatrics
Aspire Bariatrics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Hercules Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture debt financing is provided to companies in multiple sectors. | 2003 | htgc.com | Palo Alto, United States |
Investor details for Aspire Bariatrics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Aspire Bariatrics
3 dated milestones of Aspire Bariatrics across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Aspire Bariatrics is founded.
- Funding First funding round of $16.2M.
- Funding Latest funding round, Series A, of $4.6M.
Competitors of Aspire Bariatrics
Aspire Bariatrics has 3 listed competitors in our database, 3 of them funded. They include EnteroMedics, Elira and Endosphere.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enteromedics.com | 2002 | Saint Paul, United States | $62.1M | 63 | Satiety induction through vagal nerve block | |
| elira.com | 2004 | St. Louis, United States | $8.63M | Wearable neurostimulation devices for appetite suppression are developed by Elira. | ||
| endosphereinc.com | 2006 | Columbus, United States | $6.45M | Provides a duodenal insertable implant for effective obesity treatment. |
Detailed competitors of Aspire Bariatrics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aspire Bariatrics
The website of Aspire Bariatrics (aspirebariatrics.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with Aspire Bariatrics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Aspire Bariatrics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Obesity
3 companies that operate in the same segment as Aspire Bariatrics (Obesity) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Satiety induction through digestable gastric balloon introduced via a swallowed capsule | 2009 | Wellesley, Massachusetts, United States | USD 174.04 M | USD 32.11 M | 137 | |
Bioinformatics platform is provided for biomarkers and drug discovery. | 2015 | Vallejo, California, United States | USD 293.9 M | USD 8.99 M | 64 | |
Disease-modifying therapies for metabolic diseases are developed. | 2008 | Berkeley, California, United States | USD 385.52 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aspire Bariatrics
Complete news archive for Aspire Bariatrics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aspire Bariatrics
Aspire Bariatrics was founded in 2004 and raised its 1st funding round 7 years after it was founded.
Aspire Bariatrics is headquartered in King Of Prussia, United States. It is registered at King Of Prussia, Pennsylvania, United States.
Aspire Bariatrics is a funded company, having raised a total of $29.44M across 5 funding rounds to date. The company's 1st funding round was a Series A of $16.21M, raised on Dec 2011.
Aspire Bariatrics has 7 employees.
Aspire Bariatrics, Inc. is engaged in providing innovative weight loss solutions through medical devices. The companys primary product, AspireAssist, was developed to assist patients in managing weight loss. Operations are being wound down due to financial challenges caused by the COVID-19 pandemic, leading to the withdrawal of AspireAssist from the market as of April 8, 2022. The sector served includes healthcare with a focus on non-surgical weight loss interventions. No safety or effectiveness issues are associated with the product withdrawal.
Aspire Bariatrics's top competitors include EnteroMedics, Elira and Endosphere.
Aspire Bariatrics offers AspireAssist.
Aspire Bariatrics has 1 investor. Key investors include Hercules Capital.
Aspire Bariatrics operates through Aspire Bariatrics, Inc..
The website of Aspire Bariatrics receives about 681 thousand visits a month.